Serum Institute seeks Covovax’s inclusion in Covid vaccination drive for 12 years and above

India’s drug regulator had granted restricted emergency use authorisation to Covovax for the 12 to 17 years age group subject to certain conditions on March 9 and for 18 years and above on December 28.